Eli Lilly and Company
LLY
NYSE
$324.31
-$5.70-1.73%
Volume1,407,537
09/30/2022 12:11PM Eastern
Quotes delayed
| 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 6.49B | 7.81B | 8.00B | 6.77B | 6.74B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.49B | 7.81B | 8.00B | 6.77B | 6.74B |
| Cost of Revenue | 1.43B | 2.07B | 2.15B | 1.43B | 1.53B |
| Gross Profit | 5.06B | 5.74B | 5.85B | 5.34B | 5.21B |
| SG&A Expenses | 1.53B | 1.46B | 1.52B | 1.51B | 1.61B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.74B | 5.15B | 5.62B | 4.65B | 4.80B |
| Operating Income | 1.74B | 2.66B | 2.38B | 2.13B | 1.94B |
| Income Before Tax | 1.09B | 2.05B | 1.84B | 1.25B | 1.59B |
| Income Tax Expenses | 138.40M | 150.70M | 113.80M | 135.20M | 203.70M |
| Earnings from Continuing Operations | 952.50M | 1.90B | 1.73B | 1.11B | 1.39B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 952.50M | 1.90B | 1.73B | 1.11B | 1.39B |
| EBIT | 1.74B | 2.66B | 2.38B | 2.13B | 1.94B |
| EBITDA | 2.09B | 3.10B | 2.82B | 2.51B | 2.31B |
| EPS Basic | 1.06 | 2.11 | 1.90 | 1.22 | 1.53 |
| Normalized Basic EPS | 1.15 | 1.83 | 1.36 | 1.43 | 1.27 |
| EPS Diluted | 1.05 | 2.10 | 1.89 | 1.22 | 1.53 |
| Normalized Diluted EPS | 1.14 | 1.82 | 1.36 | 1.42 | 1.27 |
| Average Basic Shares Outstanding | 900.30M | 903.70M | 909.56M | 906.70M | 907.30M |
| Average Diluted Shares Outstanding | 902.90M | 906.40M | 909.56M | 910.80M | 910.40M |
| Dividend Per Share | 0.98 | 0.98 | 0.85 | 0.85 | 0.85 |
| Payout Ratio | 92.78% | 46.53% | 44.80% | 69.40% | 55.27% |
